UPDATE 1-FDA asks Teva Pharmaceutical for further study on Huntington's drug

JERUSALEM, May 31 (Reuters) - Approval for Israel-based Teva Pharmaceutical Industries' drug to treat the neurological disorder chorea has been held up by U.S. regulators seeking further blood studies, the company said on Tuesday.